Clinical Trial Update: Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment [Phase 4]

View source ↗

Summary

Phase 4 study assessing the efficacy of switching stabilized schizophrenia patients from conventional antipsychotics to an atypical antipsychotic, sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED